Investigation Into Delay to Diagnosis of Alzheimer's Disease With Exelon (InDDEx)

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Alzheimer DiseaseCognition Disorders
Interventions
DRUG

Rivastigmine

Trial Locations (15)

10016

NYU Medical Center, New York

19106

Clinical Studies, Ltd., Philadelphia, Philadelphia

27710

Duke University Medical Center, Durham

33176

Miami Research Associates, Miami

33321

Neuromedical Research Institute (Offices in Ft. Lauderdale, Miami Beach and Boca Raton), Fort Lauderdale

34285

Center for Clinical Trials and Research, Venice

46202

Indiana University Alzheimer's Center, Indianapolis

63104

St. Louis University, St Louis

73118

Pahl Brain Associates, P.C., Oklahoma City

75235

St. Paul Medical Center, Dallas

80220

University of Colorado Health Sciences Center, Denver

85381

Medici Research Centers, Peoria

92868

University of California, Irvine, Orange

98108

University of Washington, Seattle, Seattle

08701

Alzheimer's Research Corporation, Lakewood

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY